Abstract:Objective To investigate the incidence and related factors of colorectal cancer, discuss the pathogenesis of colorectal cancer so as to provide reference for prevention, screening, diagnosis, treatment and prognosis assessment of colorectal cancer Methods A total of 620 cases of colorectal cancer patients who underwent surgical treatment in the First Hospital of Qiqihar from January 2008 to December 2014 were selected. The clinical data of the patients were collected and retrospectively analyzed which included patients’ demographic characteristics,clinical symptoms, tumor location, pathological type, and degree of differentiation, Dukes staging and laboratory tests, etc. Using EpiData 3.0 software data base was established, using SPSS 20.0 software the data were statistically analyzed. Results In the patients with colorectal cancer, there were 368 males (59.4%) and 252 women (40.6%). Rectal cancer occurred in 287 patients which accounted for 46.3%, and colon cancer occurred in 333 patients accounting for 53.7%. The initial symptoms of the patients were abdominal pain, melena and abdominal distension.of the patients with colorectal cancer, 300 cases had positive fecal occult blood, accounting for 48.4%; 320 cases had negative fecal occult blood (51.6%). Tumor marker CEA was positive in 357 cases which accounted for 57.6% and negative in 263 cases (42.4%); CA199 was positive in 197 cases (31.8%) and negative in 423 cases (68.2%).In the patients with colorectal cancer, there were 563 cases of adenocarcinomas (90.8%), 52 cases of mucinous carcinoma (8.4%), 3 cases of signet-ring cell carcinoma (0.5%), and 2 cases of undifferentiated carcinoma (0.3%).In the patients with colorectal cancer, 230 were in Dukes stage A (37.1%), 130 in Dukes stage B (21.0%), 186 in Dukes stage C (30.0%), and 74 in Dukes stage D (11.9%). Conclusions The analytical results of demographic characteristics, clinical symptoms and pathological characteristics of colorectal carcinoma can provide reference for the diagnosis and treatment of colorectal cancer. We should strengthen the screening of high-risk people, early detection, early diagnosis and early treatment, so as to improve the survival rate and the quality of life of the patients.